Company Name: Aduro Biotech
Aduro Biotech is a clinical stage cancer immunotherapy company. The company uses is proprietary live, attenuated, double-deleted (LADD) Listeria monocytogenes and cyclic dinucleotides (CDNs) platforms to develop immunotherapies for various cancers. The company’s lead product candidate is designed to target metastatic pancreatic cancer.
Ticker Symbol: ADRO (NASDAQ)
Company Website: www.aduro.com
Social Media: Aduro BioTech LinkedIn
Headquarters: Berkeley, California